Literature DB >> 16126231

Molecular modeling of blood-brain barrier nutrient transporters: in silico basis for evaluation of potential drug delivery to the central nervous system.

David D Allen1, Werner J Geldenhuys.   

Abstract

For drugs that act in the brain, the blood-brain barrier (BBB) is a considerable physical barrier which influences the distribution of drugs to the brain. The BBB is essentially impermeable for hydrophilic and/or charged compounds. Nutrient membrane transporters have an important physiological role in the transport of essential substances across the BBB required for normal brain function. We and others have shown that these transporters may have utility as drug delivery vectors, thereby increasing brain distribution of these compounds via these systems. In this review, we evaluate molecular (in silico) models of BBB transport proteins. Few BBB membrane transporters have been crystallized, but their crystal structures have a possibility for use in homology modeling. Other techniques commonly used are 2D quantitative structure-activity relationships (QSAR), as well as 3D-QSAR techniques including comparative molecular field analysis (CoMFA) and comparative similarity index analysis (CoMSIA). Each of these models provides valuable information for ascertaining their potential basis for BBB transport and brain drug delivery.

Mesh:

Substances:

Year:  2005        PMID: 16126231     DOI: 10.1016/j.lfs.2005.06.004

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  6 in total

1.  Identification of Novel Agents for the Treatment of Brain Metastases of Breast Cancer.

Authors:  Vinay K Venishetty; Werner J Geldenhuys; Tori B Terell-Hall; Jessica I G Griffith; Gregory R Sondag; Fayez F Safadi; Paul R Lockman
Journal:  Curr Cancer Drug Targets       Date:  2017       Impact factor: 3.428

2.  Expression profiling of the solute carrier gene family in the mouse brain.

Authors:  Amber Dahlin; Josh Royall; John G Hohmann; Joanne Wang
Journal:  J Pharmacol Exp Ther       Date:  2009-01-29       Impact factor: 4.030

3.  Predictive screening model for potential vector-mediated transport of cationic substrates at the blood-brain barrier choline transporter.

Authors:  Werner J Geldenhuys; Vamshi K Manda; Rajendar K Mittapalli; Cornelis J Van der Schyf; Peter A Crooks; Linda P Dwoskin; David D Allen; Paul R Lockman
Journal:  Bioorg Med Chem Lett       Date:  2009-12-28       Impact factor: 2.823

4.  Polymer-drug interactions in tyrosine-derived triblock copolymer nanospheres: a computational modeling approach.

Authors:  Aurora D Costache; Larisa Sheihet; Krishna Zaveri; Doyle D Knight; Joachim Kohn
Journal:  Mol Pharm       Date:  2009 Sep-Oct       Impact factor: 4.939

Review 5.  Toward a magic or imaginary bullet? Ligands for drug targeting to cancer cells: principles, hopes, and challenges.

Authors:  Monika Toporkiewicz; Justyna Meissner; Lucyna Matusewicz; Aleksander Czogalla; Aleksander F Sikorski
Journal:  Int J Nanomedicine       Date:  2015-02-17

Review 6.  Nanoparticles for Targeted Brain Drug Delivery: What Do We Know?

Authors:  Rúben G R Pinheiro; Ana Joyce Coutinho; Marina Pinheiro; Ana Rute Neves
Journal:  Int J Mol Sci       Date:  2021-10-28       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.